Poland· PL-100523963

Setinin

A quetiapine product containing quetiapinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC N05AH04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSetininATCN05AH04REGISTER NO.PL-100523963PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Quetiapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AH04 (quetiapine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Quetiapine · ATC N05AH04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of quetiapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.19 in United States to $3.93 in Switzerland — a ×20 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Quetiapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.93
  • ES Spain$2.46
  • IT Italy$2.42
  • FR France$0.90
  • US United States$0.19 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Quetiapinum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
N05AH04
ATC class
Quetiapine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909991583842
    60 szt.
    PLN 90.73
  • gtin
    05909991583835
  • gtin
    05909991583859

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

559 interactions on record for quetiapine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quetiapine · interactions on record

559 records

  • 61 severe
  • 281 moderate
  • 7 minor
  • 132 info

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe

78 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quetiapine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quetiapine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Quetialan, Quetialan 4 Tage Startpackung
  • Belgium · Ketyalix, Quetiapin Retard Sandoz
  • Bulgaria · Centroqueen, Бревенокс
  • Cyprus · Aquetia, Ketipine
  • Czechia · Derin, Derin Prolong
  • Germany · Aquetia, Desiquet
  • Denmark · Antoreq, Biquetan
  • Estonia · Ketipinor, Kventiax
  • Spain · Atrolak Prolong, Ketyalix
  • Finland · Biquetan, Ketipinor
  • France · Lp, Queliva
  • United Kingdom (Northern Ireland) · Alaquet Xl, Atrolak Xl
  • Greece · Anaquetan Xr, Aquetia
  • Croatia · Kventiax, Kventiax Sr
  • Hungary · Ketilept, Ketilept Prolong
  • Ireland · Notiabolfen Xl, Quentiax Sr
  • Iceland · Quetiapin Actavis, Quetiapin Krka
  • Italy · Akelya, Quentiax
  • Lithuania · Hedonin, Ketipinor
  • Luxembourg · Aquetia, Quetiapine Eg
  • Latvia · Ketipinor, Kventiax
  • Malta · Quetex, Quetex Xr 50mg
  • Netherlands · Aquetia, Quetiapine
  • Norway · Quetiapin Krka, Quetiapin Orion
  • Portugal · Anaquetan Xr, Aquetia
  • Romania · Kventiax, Kventiax Ep
  • Sweden · Biquetan, Quetiapin Hexal
  • Slovenia · Kvelux, Kvelux Sr
  • Slovakia · Derin, Derin Prolong

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba1a1177-3ec8-477a-95ca-cdb3c287c0a6
GET /v1/drugs/ba1a1177-3ec8-477a-95ca-cdb3c287c0a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "05909991583835 ¦ Rp ¦ 163541\n30 tabl.\n05909991583842 ¦ Rp ¦ 163542\n60 tabl.\n05909991583859 ¦ Rp ¦ 163543\n90 tabl.",
  "substance": "Quetiapinum 200 mg",
  "common_name": "Quetiapinum",
  "pl_product_id": "100523963",
  "pozwolenie_nr": "288/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-08-29"
}

See everything about quetiapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.